217 related articles for article (PubMed ID: 21338872)
1. Cognitive enhancement: promises and perils.
Hyman SE
Neuron; 2011 Feb; 69(4):595-8. PubMed ID: 21338872
[TBL] [Abstract][Full Text] [Related]
2. Cognitive enhancers: molecules, mechanisms and minds.
Frenguelli BG
Neuropharmacology; 2013 Jan; 64():1. PubMed ID: 22985720
[No Abstract] [Full Text] [Related]
3. Drugs influencing cognitive function.
Kuruvilla A; Devi V
Indian J Physiol Pharmacol; 1994 Oct; 38(4):241-51. PubMed ID: 7883287
[No Abstract] [Full Text] [Related]
4. The Mind Bending Quest for Cognitive Enhancers.
Arce E; Ehlers MD
Clin Pharmacol Ther; 2017 Feb; 101(2):179-181. PubMed ID: 27706806
[TBL] [Abstract][Full Text] [Related]
5. [Hippocampus: a target for cognition enhancers].
Arushanian EB; Beĭer EV
Eksp Klin Farmakol; 2007; 70(4):59-65. PubMed ID: 18078044
[TBL] [Abstract][Full Text] [Related]
6. Preclinical research into cognition enhancers.
Sarter M
Trends Pharmacol Sci; 2006 Nov; 27(11):602-8. PubMed ID: 16997388
[TBL] [Abstract][Full Text] [Related]
7. The changing face of insulin receptors.
Darlington CL
Curr Opin Investig Drugs; 2007 Nov; 8(11):885-6. PubMed ID: 17979021
[No Abstract] [Full Text] [Related]
8. [Nootropes (cognition enhancers) and neuroprotectors].
Vornin TA; Seredenin SB
Eksp Klin Farmakol; 2007; 70(4):44-58. PubMed ID: 18078043
[TBL] [Abstract][Full Text] [Related]
9. [Cognitive enhancement effect of piracetam in patients with mild cognitive impairment and dementia].
Tariska P; Paksy A
Orv Hetil; 2000 May; 141(22):1189-93. PubMed ID: 10853348
[TBL] [Abstract][Full Text] [Related]
10. Cognitive enhancers for the treatment of neuropsychiatric disorders: clinical and preclinical investigations.
Kantak KM; Hofmann SG
Pharmacol Biochem Behav; 2011 Aug; 99(2):113-5. PubMed ID: 21316387
[No Abstract] [Full Text] [Related]
11. Cognitive enhancers (nootropics). Part 1: drugs interacting with receptors.
Froestl W; Muhs A; Pfeifer A
J Alzheimers Dis; 2012; 32(4):793-887. PubMed ID: 22886028
[TBL] [Abstract][Full Text] [Related]
12. Cognitive Enhancement: Treating or Cheating?
Whetstine LM
Semin Pediatr Neurol; 2015 Sep; 22(3):172-6. PubMed ID: 26358427
[TBL] [Abstract][Full Text] [Related]
13. Drugs for cognitive loss and dementia.
Treat Guidel Med Lett; 2010 Mar; 8(91):19-24. PubMed ID: 20179667
[No Abstract] [Full Text] [Related]
14. Experts urge smart thinking on cognitive enhancers.
Morris K
Lancet Neurol; 2008 Jun; 7(6):476-7. PubMed ID: 18485312
[No Abstract] [Full Text] [Related]
15. Expectations regarding cognitive enhancement create substantial challenges.
Racine E; Forlini C
J Med Ethics; 2009 Aug; 35(8):469-70. PubMed ID: 19644002
[TBL] [Abstract][Full Text] [Related]
16. Focusing the Neuroscience and Societal Implications of Cognitive Enhancers.
Savulich G; Piercy T; Brühl AB; Fox C; Suckling J; Rowe JB; O'Brien JT; Sahakian BJ
Clin Pharmacol Ther; 2017 Feb; 101(2):170-172. PubMed ID: 27557349
[TBL] [Abstract][Full Text] [Related]
17. Emerging cognitive enhancing drugs.
Buccafusco JJ
Expert Opin Emerg Drugs; 2009 Dec; 14(4):577-89. PubMed ID: 19772371
[TBL] [Abstract][Full Text] [Related]
18. Cognition enhancers between treating and doping the mind.
Lanni C; Lenzken SC; Pascale A; Del Vecchio I; Racchi M; Pistoia F; Govoni S
Pharmacol Res; 2008 Mar; 57(3):196-213. PubMed ID: 18353672
[TBL] [Abstract][Full Text] [Related]
19. [Ginkgo Biloba as a cognitive enhancer].
Arushanian EB; Beĭer EV
Eksp Klin Farmakol; 2008; 71(4):57-63. PubMed ID: 18819443
[TBL] [Abstract][Full Text] [Related]
20. 'Smart drugs': do they work? Are they ethical? Will they be legal?
Rose SP
Nat Rev Neurosci; 2002 Dec; 3(12):975-9. PubMed ID: 12461554
[No Abstract] [Full Text] [Related]
[Next] [New Search]
